My bookmarksSign up free
Source

Commission Regulation (EU) 2018/1556 of 17 October 2018 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (Text with EEA relevance.)

Commission Regulation (EU) 2018/1556 of 17 October 2018 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (Text with EEA relevance.)

Regulation (EU) 2018/1556 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Rejected health claim Application — Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Stablor®, a drink preparation with defined macro- and micronutrient composition and specific proportion of amino acids (tryptophan to neutral amino acids ratio) In the context of a well-balanced diet and a mild caloric restriction, the addition of Stablor® contributes to decrease visceral fat while preserving lean mass in overweight or obese subjects with abdominal fat and cardiometabolic risk factors. Q-2016-00319 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Curcumin Curcumin contributes to the normal functioning of joints. Q-2016-00856 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data A carbohydrate:protein (CHO:P) ratio ≤ 1.8 on an energy basis in the context of an energy-restricted diet and body weight Helps to achieve a reduction in body weight and body fat when consumed as part of an energy restricted diet (< 8 368  kJ/2 000 kcal/day) for a minimum of 12 weeks. Q-2016-00436 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Vibigaba (germinated brown rice) In the context of an energy-restricted diet contributes to weight loss. Q-2017-00032 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Vibigaba (germinated brown rice) Contributes to the maintenance of normal blood glucose levels. Q-2017-00033 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Vibigaba (germinated brown rice) Contributes to the maintenance of normal blood pressure. Q-2017-00031 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Vibigaba (germinated brown rice) Contributes to the maintenance of normal blood cholesterol levels. Q-2017-00030

Other acts of the same type
Commission Implementing Regulation (EU) 2025/1176 of 23 May 2025 specifying the pre-qualification and award criteria for auctions for the deployment of energy from renewable sourcesCommission Implementing Regulation (EU) 2025/1178 of 23 May 2025 on laying down rules for the application of Regulation (EU) 2024/1735 of the European Parliament and of the Council as regards the list of net-zero technology final products and their main specific components for the purposes of assessing the contribution to resilienceCommission Delegated Regulation (EU) 2025/1463 of 23 May 2025 amending Regulation (EU) 2024/1735 of the European Parliament and of the Council as regards the identification of sub-categories within net-zero technologies and the list of specific components used for those technologiesCommission Implementing Regulation (EU) 2025/955 of 22 May 2025 on the registration of the geographical indication Savolainen mustikkakukko (PGI) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/956 of 22 May 2025 on the registration of the geographical indication Sal de Rio Maior / Flor de Sal de Rio Maior (PDO) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1072 of 22 May 2025 amending Annex I to Implementing Regulation (EU) 2023/594 laying down special disease control measures for African swine feverCommission Implementing Regulation (EU) 2025/1085 of 22 May 2025 amending Annexes V and XIV to Implementing Regulation (EU) 2021/404 as regards the entries for Canada, the United Kingdom and the United States in the lists of third countries, territories or zones thereof authorised for the entry into the Union of consignments of poultry and germinal products of poultry, and of fresh meat of poultry and game birdsCommission Implementing Regulation (EU) 2025/1093 of 22 May 2025 laying down rules for the application of Regulation (EU) 2023/1115 of the European Parliament and of the Council as regards a list of countries that present a low or high risk of producing relevant commodities for which the relevant products do not comply with Article 3, point (a)Commission Delegated Regulation (EU) 2025/928 of 21 May 2025 amending Regulation (EU) 2019/125 of the European Parliament and of the Council concerning trade in certain goods which could be used for capital punishment, torture or other cruel, inhuman or degrading treatment or punishmentCommission Implementing Regulation (EU) 2025/929 of 21 May 2025 approving 1,2-Benzisothiazol-3(2H)-one (BIT) as an existing active substance for use in biocidal products of product-types 6 and 13 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/930 of 21 May 2025 granting a Union authorisation for the single biocidal product Fernox Biocide AF10 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/935 of 21 May 2025 amending Implementing Regulation (EU) 2022/918 laying down technical specifications of data requirements for the topic Global Value Chains pursuant to Regulation (EU) 2019/2152 of the European Parliament and of the Council

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next